Oral candidosis: Characterization of a sample of recurrent infections and study of resistance determinants

New Microbiologica

Volumn 34, Issue 4, 2011, Pages 379-389

  Gallè, Francesca ^a   Sanguinetti, Maurizio ^b   Colella, Giuseppe ^c   Di Onofrio, Valeria ^a   Torelli, Riccardo ^b   Rossano, Fabio ^d   Liguori, Giorgio ^a  

^a UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Eectrophoretic karyotyping; Recurrent oral candidosis; Resistance determinants; Restriction fragment length polymorphism

Indexed keywords

ANTIFUNGAL AGENT; CARRIER PROTEIN; CDR1 PROTEIN, CANDIDA ALBICANS; FLUCONAZOLE; FUNGAL PROTEIN; GLYCOPROTEIN P; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; DRUG EFFECT; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THRUSH;

ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; FUNGAL PROTEINS; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; P-GLYCOPROTEIN; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN-SERINE-THREONINE KINASES; RECURRENCE;

EID: 82755174193     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. AKPAN A., MORGAN R. (2002). Oral candidiasis. Postgrad. Med. J. 78, 455-59. (Pubitemid 34948150)
2. ANDERSON J., SRIKANTHA T., MORROW B., MIYASAKI S.H., WHITE T.C., AGABIAN N., SCHMID J., SOLL D.R. (1993). Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans. J. Clin. Microbiol. 31, 1472-1480. (Pubitemid 23164407)
3. BANERJEE S.N., EMORI T.G., CULVER D.H. (1991). Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am. J. Med. 91, 86S-89S.
4. BARCHIESI F., FALCONI DI FRANCESCO L., ARZENI D., CASELLI F., GALLO D., SCALISE G. (1999). Electrophoretic Karyotyping and Triazole Susceptibility of Candida glabrata Clinical Isolates. Eur. J. Clin. Microbiol. Infect. Dis. 18, 184-187. (Pubitemid 29527952)
5. BARTON R.C., VAN BELKUM A., SCHERER S. (1995). Stability of karyotype in serial isolates of Candida albicans from neutropenic patients. J. Clin. Microbiol. 33, 794-796.
6. BENNETT J.E., IZUMIKAWA K., MARR K.A. (2004). Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob. Agents. Chemother. 48, 1773-1777. (Pubitemid 38544388)
7. BOCCIA S., POSTERARO B., LA SORDA M., VENTO G., MATASSA P.G., TEMPERA A., PETRUCCI S., FADDA G. (2002). Genotypic analysis by 27A DNA fingerprinting of Candida albicans strains isolated during an outbreak in a neonatal intensive care unit. Infect. Control. Hosp. Epidemiol. 23, 281-284. (Pubitemid 34525275)
8. CENTER FOR DISEASE CONTROL AND PREVENTION. (2001). National Nosocomial Infections Surveillance (NNIS) report, data summary from January 1992-June 2001. Am. J. Infect. Control. 29, 404-421.
9. CHEN S.C.A., HALLIDAY C.L., MEYERW. (2002). A review of nucleic acidbased diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays. Med. Mycol. 40, 333-357. (Pubitemid 34965653)
10. CHEN K.W., LO H.J., LIN Y.H., LI S.Y. (2005). Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J. Med. Microbiol. 54, 249-258.
11. COOGAN M.M., FIDEL P.L., KOMESU M.C., MAEDA N., SAMARANAYAKE L.P. (2006). Candida and Mycotic Infections. Adv. Dent. Res. 19, 130-138.
12. DI FRANCESCO L.F., BARCHIESI F., CASELLI F., CIRIONI O., SCALISE G. (1999). Comparison of four methods for DNA typing of clinical isolates of Candida glabrata. J. Med. Microbiol. 48, 955-963. (Pubitemid 29525265)
13. EGGIMANN P., GARBINO J., PITTET D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3, 685-702. (Pubitemid 37345347)
14. FANELLO S., BOUCHARA J.P., SAUTERON M., DELBOS V., PAROT E., MAROT-LEBLOND A., MOALIC E., LE FLOHICC A.M., BRANGERD B. (2006). Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. J. Med. Microbiol. 55, 223-228. (Pubitemid 43201751)
15. FRIDKIN S.K., JARVIS W.R. (1996). Epidemiology of Nosocomial Fungal Infections. Clin. Microbiol. Rev. 9, 499-511. (Pubitemid 26366535)
16. GYGAX S.E., VERMITSKY J.P., CHADWICK S.G., SELF M.J., ZIMMERMAN J.A., MORDECHAI E., ADELSON M.E., TRAMA J.P. (2008). Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay. Antimicrob. Agents Chemother. 52, 3424-3426.
17. HOBSON R.P. (2003). The global epidemiology of invasive Candida infections - is the tide turning? J. Hosp. Infect. 55, 159168.
18. HUANG Y.C., SU L.H., WU T.L., LIN T.Y. (2004). Genotyping analysis of colonizing candidal isolates from very-low-birthweight infants in a neonatal intensive care unit. J. Hosp. Infect. 58, 200-203.
19. KOFLA G., RUHNKE M. (2007). Development of a new real-time TaqMan PCR assay for quantitative analyses of Candida albicans resistance genes expression. J. Microbiol. Methods. 68, 178-183. (Pubitemid 46054330)
20. KURIYAMA T., WILLIAMS D.W., BAGG J., COULTER W.A., READY D., LEWIS M.A.O. (2005). In vitro susceptibility of oral Candida to seven antifungal agents. Oral. Microbiol. Immunol. 20, 349-353. (Pubitemid 41564346)
21. LEPAK A., NETT J., LINCOLN L., MARCHILLO K., ANDES D. (2006). Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrob. Agents Chemother. 50, 1311-1319.
22. LIGUORI G., LUCARIELLO A., COLELLA G., DE LUCA A., MARINELLI P. (2007). Rapid identification of Candida species in oral rinse solutions by PCR. J. Clin. Pathol. 60, 1035-1039. (Pubitemid 47441938)
23. LIGUORI G., DI ONOFRIO V., LUCARIELLO A., GALLÉ F., SIGNORIELLO G., COLELLA G., D'AMORA M., ROSSANO F. (2009). Oral candidiasis: a comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral. Microbiol. Immunol. 24,76-78.
24. LIGUORI G., GALLÉ F., LUCARIELLO A., DI ONOFRIO V., ALBANO L., MAZZARELLA G., D'AMORA M., ROSSANO F. (2010). Comparison between multiplex PCR and phenotypic systems for Candida spp. identification. New Microbiol. 33, 63-7.
25. MARR K.A., LYONS C.N., RUSTAD T.R., BOWDEN R.A., WHITE T.C. (1998). Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob. Agents Chemother. 42, 2584-2589. (Pubitemid 28462897)
26. MAGEE P.T., BOWDIN L., STAUDINGER J. (1992). Comparison of molecular typing methods for Candida albicans. J. Clin. Microbiol. 30, 2674-2679.
27. MARR K.A., LYONS C.N., HA K., RUSTAD T.R., WHITE T.C. (2001). Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob. Agents Chemother. 45, 52-59. (Pubitemid 32039093)
28. LÓPEZ-RIBOT J.L., MCATEE R.K., KIRKPATRICK W.R., PEREA S., FROST PATTERSON T. (2000). Comparison of DNA-based typing methods to assess genetic diversity and relatedness among Candida albicans clinical isolates. Rev. Iberoam. Micol. 17, 49-54.
29. PARK S., PERLIN D.S. (2005). Establishing surrogate markers for fluconazole resistance in Candida albicans. Microb. Drug Resist. 11, 232-238. (Pubitemid 41434167)
30. PFALLER M.A., MESSER S.A., HOUSTON A., RANGELFRAUSTOM. S., WIBLIN T., BLUMBERG H.M., EDWARDS J.E., JARVIS W., MARTIN M.A., NEU H.C., SAIMAN L., PATTERSON J.E., DIBB J.C., ROLDAN C.M., RINALDI M.G., WENZEL R.P. (1998). National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn.Microbiol. Infect. Dis. 31, 289-296. (Pubitemid 28212057)
31. REX J.H., PFALLER M.A., GALGIANI J.N., ET AL. (1997). Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24, 235-247 (Pubitemid 127774263)
32. REX J.H., PFALLERM.A. (2002). Has antifungal susceptibility testing come of age? Clin. Infect. Dis. 35, 982-989. (Pubitemid 35178316)
33. RHO J., SHIN J.H., SONG J.W., PARKM.R., KEE S.J., JANG S.J., PARK Y.K., SUH S.P., RYANG D.W. (2004). Molecular investigation of two consecutive nosocomial clusters of Candida tropicalis candiduria using Pulsed-Field Gel Electrophoresis. J. Microbiol. 42, 80-86. (Pubitemid 38952348)
34. RICHARDSONM.D. (2005). Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56, 5-11.
35. ROGERS D., BARKER K.S. (2003). Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 47, 1220-1227. (Pubitemid 36368578)
36. RUHNKE M. (2006). Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Curr. Drug Targets. 7, 495-504. (Pubitemid 43744840)
37. SAMARANAYAKE Y.H., SAMARANAYAKE L.P., TSANG P.C., WONG K.H., YEUNG K.W. (2001). Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIVinfected southern Chinese cohort. J. Oral Pathol. Med. 30, 336-346. (Pubitemid 32620846)
38. SAMARANAYAKE Y.H., SAMARANAYAKE L.P., DASSANAYAKE R.S., YAU J.Y., TSANG W.K., CHEUNG B.P., YEUNG K.W. (2003). Genotypic shuffling of sequential clones of Candida albicans in HIV-infected individuals with and without symptomatic oral candidiasis. J. Med. Microbiol. 52, 349-359. (Pubitemid 36515298)
39. SANGLARD D., ODDS F.C. (2002). Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2, 73-85. (Pubitemid 36114141)
40. SANGUINETTI M., POSTERARO B., FIORI B., RANNO S., TORELLI R., FADDA G. (2005). Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal Resistance. Antimicrob. Agents Chemother. 49, 668-679. (Pubitemid 40175679)
41. SCHERER S., STEVENS D.A. (1998). A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc. Natl. Acad. Sci. USA. 85, 1452-1456.
42. SHIN J.H., SHIN D.H., SONG J.W., KEE S.J., SUH S.P., RYANG D.W. (2001). Electrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or recurrent fungemia. J. Clin. Microbiol. 39, 1258-1263. (Pubitemid 32275417)
43. SHIN J.H., PARK M.R., SONG J.W., SHIN D.H., JUNG S.I., CHO D., KEE S.J., SHIN M.G., SUH S.P., RYANG D.W. (2004). Microevolution of Candida albicans strains during catheter-related candidemia. J. Clin. Microbiol. 42, 4025-4031. (Pubitemid 39296119)
44. SHIN J.H., KIM M.N., SHIN D.H., JUNG S.I., KIM K.J., CHO D., KEE S.J., SHIN M.G., SUH S.P., RYANG D.W. (2004). Genetic relatedness among Candida tropicalis isolates from sporadic cases of fungemia in two university hospitals in Korea. Infect. Control Hosp. Epidemiol. 25, 634-640. (Pubitemid 39095044)
45. SHIN J.H., OG Y.G., CHO D., KEE S.J., SHIN M.G., SUH S.P., RYANG D.W. (2005). Molecular epidemiological analysis of bloodstream isolates of Candida albicans from a university hospital over a five-year period. J. Microbiol. 43, 546-554. (Pubitemid 43096481)
46. SOLL D.R. (2000). The ins and outs of DNA fingerprinting of infectious fungi. Clin. Microbiol. Rev. 13, 332-370. (Pubitemid 30205430)
47. SPIESS B., SEIFARTH W., HUMMEL M., FRANK O., FABARIUS A., ZHENG C., MORZ H., HEHLMANN R., BUCHHEIDT D. (2007). DNA Microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J. Clin. Microbiol. 45, 3743-3753. (Pubitemid 350156875)
48. TAVANTI A., DAVIDSON A.D., JOHNSON E.M., MAIDEN M.C., SHAW D.J., GOW N.A., ODDS F.C. (2005). Multilocus sequence typing for differentiation of strains of Candida tropicalis. J. Clin. Microbiol. 43, 5593-600. (Pubitemid 41612336)
49. THOMPSON G.R. 3RD, PATEL P.K., KIRKPATRICK W.R., WESTBROOK S.D., BERG D., ERLANDSEN J., REDDING, S.W., PATTERSON T.F. (2010). Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109, 488-495.
50. VASQUEZ J.A., BECKLEY A., SOBEL J.D., ZERVOS M.J. (1991). Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans. J. Clin. Microbiol. 29, 962-967.
51. YANG Y.L., LO H.J. (2001). Mechanisms of antifungal agent resistance. J. Microbiol. Immunol. Infect. 34, 79-86.
52. WILLIAMS D.W., LEWISM.A. (2000). Isolation and identification of Candida from the oral cavity. Oral Dis. 6, 3-11. (Pubitemid 30090219)
53. WILSON D., THEWES S., ZAKIKHANY K., FRADIN C., ALBRECHT A., ALMEIDA R., BRUNKE S., GROSSE K., MARTIN R., MAYER F., LEONHARDT I., SCHILD L., SEIDER K., SKIBBE M., SLESIONA S., WAECHTLER B., JACOBSEN I., HUBE B. (2009). Identifying infectionassociated genes of Candida albicans in the postgenomic era. FEMS Yeast Res. 9, 688-700.